Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The immune system's response to allergen exposure is a complex process involving sensitization and effector phases. Sensitization involves IgE production and mast cell priming. Re-exposure triggers mast cell degranulation, releasing inflammatory mediators. Therapeutic strategies aim to block these mediators or induce tolerance through immunotherapy. Dysregulation of the immune system underlies all allergic diseases.
Varied, depending on the specific drug; includes blocking histamine receptors, suppressing inflammation, preventing IgE binding, and inducing immune tolerance.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Allergen Exposure).